Kazia Therapeutics Limited (NASDAQ: KZIA) Stock Information | RedChip

Kazia Therapeutics Limited (NASDAQ: KZIA) Listen to this Section


$0.39
+0.0070 ( +1.82% ) 502.6K

Kazia Therapeutics Ltd is an oncology-focused biotechnology company, developing innovative anti-cancer drugs. The group is developing paxalisib, a potential treatment for glioblastoma; Cantrixil, being developed for the treatment of ovarian cancer; and Others. The company is also developing EVT801 for the treatment of various tumors.

Market Data


Open


$0.39

Previous close


$0.39

Volume


502.6K

Market cap


$11.92M

Day range


$0.37 - $0.42

52 week range


$0.19 - $1.58

Insider Ownership Transactions

Total Amount Purchased: 0.00 | $ 0.00

Date Type Amount Purchased Purchaser
No records found.

SEC Fillings


Form Type Description Pages Date
20-f Annual reports 143 Oct 26, 2023
6-k Quarterly Reports 3 Oct 23, 2023
6-k Quarterly Reports 4 Oct 13, 2023
6-k Quarterly Reports 3 Oct 11, 2023
6-k Quarterly Reports 5 Oct 10, 2023
6-k Quarterly Reports 3 Oct 06, 2023
6-k Quarterly Reports 3 Sep 29, 2023
6-k Quarterly Reports 97 Sep 05, 2023
6-k Quarterly Reports 3 Aug 11, 2023

Latest News


Terms and Agreement

Please agree to the terms to continue using the chat feature.